Download Files:
Alogliptin (Benzoate)
SKU
HY-A0023-10 mg
Category Reference compound
Tags Apoptosis;Metabolic Enzyme/Protease, Dipeptidyl Peptidase;Ferroptosis, Metabolic Disease; Inflammation/Immunology; Cardiovascular Disease
$55 – $171
Products Details
Product Description
– Alogliptin Benzoate (SYR-322) is a potent, selective and orally active inhibitor of DPP-4 with an IC50 of <10 nM, and exhibits greater than 10,000-fold selectivity over DPP-8 and DPP-9. Alogliptin Benzoate can be used for the research of type 2 diabetes[1][2][3].
Web ID
– HY-A0023
Storage Temperature
– 4°C (Powder, sealed storage, away from moisture)
Shipping
– Room Temperature
Applications
– Metabolism-protein/nucleotide metabolism
Molecular Formula
– C25H27N5O4
Citations
– Biochem Biophys Res Commun. 2019 Apr 2;511(2):387-393. |Biol Chem. 2023 Jan 12.|Chromatography. 2015,36(1):19-24.|Sci Rep. 2019 Dec 2;9(1):18094.|Sci Signal. 2023 Jan 17;16(768):eabh1083.
References
– [1]Feng J, et, al. Discovery of alogliptin: a potent, selective, bioavailable, and efficacious inhibitor of dipeptidyl peptidase IV. J Med Chem. 2007 May 17;50(10):2297-300.|[2]Ta NN, et, al. DPP-4 (CD26) inhibitor alogliptin inhibits TLR4-mediated ERK activation and ERK-dependent MMP-1 expression by U937 histiocytes. Atherosclerosis. 2010 Dec;213(2):429-35.|[3]Hao FL, et, al. The neurovascular protective effect of alogliptin in murine MCAO model and brain endothelial cells. Biomed Pharmacother. 2019 Jan;109:181-187.|[4]Asakawa T, et, al. A novel dipeptidyl peptidase-4 inhibitor, alogliptin (SYR-322), is effective in diabetic rats with sulfonylurea-induced secondary failure. Life Sci. 2009 Jul 17;85(3-4):122-6.|[5]Moritoh Y, et al. The dipeptidyl peptidase-4 inhibitor alogliptin in combination with pioglitazone improves glycemic control, lipid profiles, and increases pancreatic insulin content in ob/ob mice. Eur J Pharmacol. 2009 Jan 14;602(2-3):448-54.
CAS Number
– 850649-62-6
Molecular Weight
– 461.51
Compound Purity
– 99.99
SMILES
– O=C(C=C(N1C[C@H](N)CCC1)N(C2=O)CC3=C(C#N)C=CC=C3)N2C.O=C(O)C4=CC=CC=C4
Clinical Information
– Launched
Research Area
– Metabolic Disease; Inflammation/Immunology; Cardiovascular Disease
Solubility
– DMSO : 25 mg/mL (ultrasonic;warming;heat to 60°C)|H2O : 14.29 mg/mL (ultrasonic;warming;heat to 60°C)
Target
– Dipeptidyl Peptidase;Ferroptosis
Isoform
– DPP-4
Pathway
– Apoptosis;Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.